ATE529536T1 - Verfahren zur identifizierung und behandlung von komplexe karyotypen zeigenden individuen - Google Patents
Verfahren zur identifizierung und behandlung von komplexe karyotypen zeigenden individuenInfo
- Publication number
- ATE529536T1 ATE529536T1 AT06840081T AT06840081T ATE529536T1 AT E529536 T1 ATE529536 T1 AT E529536T1 AT 06840081 T AT06840081 T AT 06840081T AT 06840081 T AT06840081 T AT 06840081T AT E529536 T1 ATE529536 T1 AT E529536T1
- Authority
- AT
- Austria
- Prior art keywords
- identifying
- treating individuals
- complex karyotypes
- individuals showing
- showing complex
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74128005P | 2005-12-01 | 2005-12-01 | |
| PCT/US2006/061399 WO2007065124A2 (en) | 2005-12-01 | 2006-11-30 | Methods of identifying and treating individuals exhibiting complex karyotypes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE529536T1 true ATE529536T1 (de) | 2011-11-15 |
Family
ID=37907170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06840081T ATE529536T1 (de) | 2005-12-01 | 2006-11-30 | Verfahren zur identifizierung und behandlung von komplexe karyotypen zeigenden individuen |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090197893A1 (de) |
| EP (1) | EP1960546B1 (de) |
| AT (1) | ATE529536T1 (de) |
| ES (1) | ES2372975T3 (de) |
| WO (1) | WO2007065124A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011202950B2 (en) * | 2006-04-07 | 2012-03-22 | Novartis Ag | Use of c-Src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia |
| EP2327793A1 (de) * | 2009-11-25 | 2011-06-01 | Universität Zu Köln | Pyrosequenzierungsverfahren zur Vorhersage der Reaktion eines Patienten auf eine Antikrebsbehandlung |
| JP5940771B2 (ja) * | 2010-07-12 | 2016-06-29 | アークレイ株式会社 | ａｂｌ遺伝子多型の検出用プローブおよびその用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID30460A (id) * | 1999-04-15 | 2001-12-06 | Bristol Myers Squibb Co | Inhibitor-inhibitor protein siklik tirosin kinase |
| US20090306207A1 (en) * | 2005-01-05 | 2009-12-10 | Reddy M V Ramana | Treatment of Drug-Resistant Proliferative Disorders |
| EP1906967A4 (de) * | 2005-07-26 | 2010-07-28 | Vertex Pharma | Abl-kinase-hemmung |
-
2006
- 2006-11-30 EP EP06840081A patent/EP1960546B1/de active Active
- 2006-11-30 US US12/085,733 patent/US20090197893A1/en not_active Abandoned
- 2006-11-30 WO PCT/US2006/061399 patent/WO2007065124A2/en active Application Filing
- 2006-11-30 ES ES06840081T patent/ES2372975T3/es active Active
- 2006-11-30 AT AT06840081T patent/ATE529536T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2372975T3 (es) | 2012-01-30 |
| WO2007065124A3 (en) | 2007-07-05 |
| EP1960546A2 (de) | 2008-08-27 |
| EP1960546B1 (de) | 2011-10-19 |
| WO2007065124A2 (en) | 2007-06-07 |
| US20090197893A1 (en) | 2009-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
| ATE450530T1 (de) | Zusammensetzungen zur verwendung als protein- kinase-inhibitoren | |
| ATE482213T1 (de) | Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine | |
| EA201692543A1 (ru) | Антагонисты активина-actriia и их применение для стимулирования роста кости | |
| DE602004024572D1 (de) | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen | |
| CY1112238T1 (el) | Αναστολεις μιτωτικης κινεσινης και μεθοδοι χρησης αυτων | |
| ATE420883T1 (de) | Pyrrolopyrimidine verwendbar als protein kinase inhibitoren | |
| DE602005020611D1 (de) | Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen | |
| ATE471334T1 (de) | Phosphoramidatderivate von nukleosidverbindungen zur verwendung bei der behandlung von krebs | |
| SG155947A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| DE60314500D1 (de) | Diaminopyrimidine und deren verwendung als angiogenesehemmer | |
| ATE464323T1 (de) | Zusammensetzungen und verfahren für die tumor- diagnose und behandlung | |
| IL190796A0 (en) | Compositions and their uses for gene therapy of bone conditions | |
| DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| DE60314603D1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
| ATE443260T1 (de) | Kontrastmittel und verfahren zum imaging von naaldase oder psma | |
| MX2008009886A (es) | Anticuerpos que enlazan par-2. | |
| EA201070148A1 (ru) | Соединения и способы модулирования фарнезоидного рецептора x (fxr) | |
| DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| DE602004012578D1 (de) | Als inhibitoren von c-met geeignete pyrrolzusammensetzungen | |
| DE60330161D1 (de) | Rifalazil zur behandlung von infektionen mit clostridium difficile | |
| ATE505192T1 (de) | Pharmazeutische zusammensetzung zur anwendung in der behandlung von personen mit mutant-kit- protein | |
| DE602005021766D1 (de) | Verfahren zur behandlung von atherosklerose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |